`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`TEVA PHARMACEUTICALS USA, INC. AND WATSON
`LABORATORIES, INC.
`Petitioners,
`
`v.
`MERCK SHARP & DOHME CORP.
`Patent Owner.
`
`
`Case IPR2020-01045
`Patent 7,326,708
`
`
`DECLARATION OF EMILY L RAPALINO IN SUPPORT OF PETITIONERS’
`MOTION FOR PRO HAC VICE ADMISSION OF EMILY L RAPALINO
`UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`IPR2020-01045
`Teva Ex. 1018
`
`
`
`
`
`I, Emily L. Rapalino, declare as follows:
`
`1.
`
`I obtained an A.B. from Harvard University in 1996, and M.S. from
`
`the Weizmann Institute of Science, and a J.D. from Columbia Law School in 2002.
`
`2.
`
`I am currently a partner in the law firm of Goodwin Procter LLP, a
`
`position which I have held since about 2009. In my 18 years of practice, I have
`
`focused primarily on representing clients in patent litigations involving the
`
`chemical arts in United States district courts and the Court of Appeals for the
`
`Federal Circuit. Through this work, I have gained extensive experience as a
`
`litigating attorney, particularly in patent cases.
`
`3.
`
`I am a member in good standing of the Bar of the Commonwealth of
`
`Massachusetts, the State of New Jersey, and the State of New York, and am
`
`admitted to practice before the United States District Court for the District of
`
`Massachusetts, the United States District Court for the Eastern District of New
`
`York, the United States District Court for the Southern District of New York, and
`
`the United States Court of Appeals for the Federal Circuit.
`
`4.
`
`In the last three years, I was admitted to appear pro hac vice in
`
`PGR2017-00034 and IPR2017-01256.
`
`5.
`
`I have substantial familiarity with the subject matter at issue in this
`
`proceeding. Patent Owner has asserted against Petitioners U.S. Patent No.
`
`7,326,708 (“the ’708 patent”), the patent at issue in this proceeding. In the course
`
`
`
`
`1
`
`
`IPR2020-01045
`Teva Ex. 1018
`
`
`
`
`
`of those proceedings, I have developed a strong familiarity with the ’708 patent, its
`
`prosecution history, the general subject matter to which the ’708 patent is directed,
`
`and the prior art references relied upon by Petitioner and the Patent Owner in
`
`support of their Papers. Furthermore, I have thoroughly reviewed the Petition, the
`
`Patent Owner’s Response, and accompanying Exhibits submitted in this
`
`proceeding.
`
`6.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`7.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`8.
`
`I have never been subject to any sanction or contempt citation
`
`imposed by any court or administrative body.
`
`9.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`10.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et. seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`11.
`
`I declare under penalty of perjury that the foregoing is true and
`
`correct. I further declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`
`
`
`2
`
`
`IPR2020-01045
`Teva Ex. 1018
`
`
`
`
`
`and further that these statements were made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`under section 1001 of title 18 of the United States Code, and that such willful false
`
`statements may jeopardize the validity of the application or any patent issued
`
`thereon.
`
`Executed on: July 27, 2020
`
`/Emily L. Rapalino/
`Emily L. Rapalino
`
`
`
`
`
`
`3
`
`
`IPR2020-01045
`Teva Ex. 1018
`
`